These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7193609)

  • 21. Activation of protein kinases in chronically hypoxic infant human and rabbit hearts: role in cardioprotection.
    Rafiee P; Shi Y; Kong X; Pritchard KA; Tweddell JS; Litwin SB; Mussatto K; Jaquiss RD; Su J; Baker JE
    Circulation; 2002 Jul; 106(2):239-45. PubMed ID: 12105165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Use of Nesiritide in Children With Congenital Heart Disease.
    Bronicki RA; Domico M; Checchia PA; Kennedy CE; Akcan-Arikan A
    Pediatr Crit Care Med; 2017 Feb; 18(2):151-158. PubMed ID: 27849656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resolution of calcific brown fat necrosis associated with prostaglandin therapy for cyanotic congenital heart disease in neonates: report of two cases.
    Miller SF
    Pediatr Radiol; 2004 Nov; 34(11):919-23. PubMed ID: 15185042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of hemodynamic changes in congenital heart defects on the lung function of the infant].
    Riegel K
    Monatsschr Kinderheilkd (1902); 1969 Apr; 117(4):133-7. PubMed ID: 5377479
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of maternal intravenous administration of atropine (0.5mg) on fetal breathing and heart pattern.
    Roodenburg PJ; Wladimiroff JW; Van Weering HK
    Contrib Gynecol Obstet; 1979; 6():92-7. PubMed ID: 446033
    [No Abstract]   [Full Text] [Related]  

  • 26. Atropine abolishes electroencephalogram-associated heart rate changes without an effect on respiratory sinus arrhythmia during anaesthesia in humans.
    Yli-Hankala A; Loula P; Annila P; Lindgren L; Jäntti V
    Acta Physiol Scand; 1993 Dec; 149(4):435-40. PubMed ID: 8128892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A functional umbilical cord occlusion heart rate pattern. The significance of overshoot.
    Goodlin RC; Lowe EW
    Obstet Gynecol; 1974 Jan; 43(1):22-30. PubMed ID: 4808961
    [No Abstract]   [Full Text] [Related]  

  • 28. Supportive and emergency use of prostaglandin in the neonate with congenital heart disease.
    Hussain A; al Khudhairi D
    Middle East J Anaesthesiol; 1993 Feb; 12(1):73-81. PubMed ID: 8316154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Action of atropine and complete autonomic block on cardiac adaptation to sinusoidal exercise].
    Ashkar E; Regatky EL; Narciso E
    Rev Soc Argent Biol; 1971; 46(1):51-7. PubMed ID: 5120502
    [No Abstract]   [Full Text] [Related]  

  • 30. [Ontogenic changes in cardiac rhythm during acute hypoxia in dogs and rabbits].
    Akopyan NS
    Zh Evol Biokhim Fiziol; 1975; 11(2):159-63. PubMed ID: 1217289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dilation of the ductus arteriosus by oral prostaglandin E1 derivative in cyanotic congenital heart diseases.
    Matsuura H; Saji T; Yamamoto S; Ishikita T; Aoki Y; Matsuo N
    Am Heart J; 1993 May; 125(5 Pt 1):1453-4. PubMed ID: 8480610
    [No Abstract]   [Full Text] [Related]  

  • 32. Kinetic and clinical observations in cyanotic children on propranolol therapy.
    Riopel DA; Walle T
    Clin Pharmacol Ther; 1980 Dec; 28(6):743-50. PubMed ID: 7438690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticholinergic premedication in infants: a comparison of atropine and glycopyrrolate on heart rate, demeanor, and facial flushing.
    Cozanitis DA; Jones CJ; Erkola O
    Pediatr Pharmacol (New York); 1984; 4(1):7-10. PubMed ID: 6739187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Myocardial hypoxia in newborn infants].
    Eĭgenson OB
    Pediatriia; 1990; (8):96-9. PubMed ID: 2259588
    [No Abstract]   [Full Text] [Related]  

  • 35. Pericardial extramedullary hematopoiesis in a neonate with congenital heart disease. A case report.
    Luban NL; Kapur S; DePalma L
    Acta Cytol; 1993; 37(5):729-31. PubMed ID: 8362588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proceedings: Emergency treatment of certain cyanotic heart defects with prostaglandin E2.
    Olley PM; Coceani F
    Br Heart J; 1976 Aug; 38(8):877. PubMed ID: 973917
    [No Abstract]   [Full Text] [Related]  

  • 37. [Value of pindolol in cyanotic congenital cardiopathies].
    Dupuis C; Breviere GM
    Lille Med; 1973; 18(7):828-31. PubMed ID: 4603959
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of hypoxia and its relationship with apoptosis, stem cells, and angiogenesis on the thymus of children with congenital heart defects: a morphological and immunohistochemical study.
    Ceyran AB; Şenol S; Güzelmeriç F; Tunçer E; Tongut A; Özbek B; Şavluk Ö; Aydın A; Ceyran H
    Int J Clin Exp Pathol; 2015; 8(7):8038-47. PubMed ID: 26339370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for Critical Congenital Heart Disease.
    Oster ME; Kochilas L
    Clin Perinatol; 2016 Mar; 43(1):73-80. PubMed ID: 26876122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prostaglandins in the care of the neonate with heart defects].
    Samánek M; Hruda P
    Cesk Pediatr; 1987 Feb; 42(2):71-6. PubMed ID: 3568178
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.